Divi's Laboratories Ltd.

Financial

	Divi's Lab	Laurus Labs	Neuland Laboratories
Operational Metrics
Pharmaceutical Sector
R&D as a % of Total Sales	0.91 %	5.4 %	2.79 %
Financials
5 yr Average ROE	18.3 %	20.05 %	11.99 %
5yr average Equity Multiplier	1.22	2.06	1.62
5yr Average Asset Turnover Ratio	0.56	0.74	0.72
5yr Avg Net Profit Margin	26.18 %	12.47 %	10.09 %
Price to Book	11.19	7.4	12.74
P/E	83.63	233.25	63.54
5yr Avg Cash Conversion Cycle	141.85 Days	109.81 Days	45.08 Days
Inventory Days	121.27 Days	110.32 Days	89.03 Days
Days Receivable	91.33 Days	117.42 Days	86.1 Days
Days Payable	96.31 Days	143.67 Days	113.14 Days
5yr Average Interest Coverage Ratio	1019.27	9.19	12.92
5yr Avg ROCE	23.0 %	24.17 %	16.09 %
5yr Avg Operating Profit Margin	35.36 %	24.55 %	19.31 %
5 yr average Debt to Equity	0.0	0.56	0.21
5yr CAGR Net Profit	3.05 %	-9.19 %	79.26 %
5yr Average Return on Assets	14.92 %	9.61 %	7.75 %
Shareholdings
Promoter Holding	51.89 %	27.18 %	32.64 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-0.06 %	-0.12 %	-3.58 %
Change in Mutual Fund Holding (3 Yrs)	-0.71 %	6.17 %	3.25 %

Business

	Divi's Lab	Laurus Labs	Neuland Laboratories
Product Wise Break-Up	Product Wise Break-Up Custom Synthesis 51.0 API 49.0 Nutraceuticals 0 Bio 0 Generics FDF 0 Ingredients 0 Synthesis 0 Generic API 0 Generic Drug Substances(GDS) 0 Custom Manufacturing Solutions(CMS) 0	Product Wise Break-Up API 0 Bio 3.0 Ingredients 0 Custom Manufacturing Solutions(CMS) 0 Custom Synthesis 0 Nutraceuticals 0 Formulations 27.0 Generic Drug Substances(GDS) 0 Active Pharmaceutical Ingredient (API) 46.0 Synthesis 24.0	Product Wise Break-Up API 0 Bio 0 Ingredients 0 Custom Manufacturing Solutions(CMS) 42.0 Custom Synthesis 0 Nutraceuticals 0 Generics FDF 0 Formulations 52.0 Generic API 0 Synthesis 0 Others 6.0
Location Wise Break-Up	Location Wise Break-Up Europe 51.77 USA 18.25 Asia Pacific 12.96 India 12.54 Rest of the World 4.47 North America 0 Others 0.01	Location Wise Break-Up Europe 27.0 USA 0 Asia Pacific 0 India 0 North America 17.0 Rest of the World 56.0	Location Wise Break-Up Europe 30.51 USA 39.54 Asia Pacific 0 India 19.51 North America 0 Rest of the World 10.44
Brand Wise Break-Up	Brand Wise Break-Up Naproxen and Dextromethorphan HBr 26.0 Others 74.0	-	-
Asset Break-Up	Asset Break-Up India 99.96 USA 0.04	-	Asset Break-Up USA 0 India 100.0